로딩 중…
지수 로딩 중…
Iovance Biotherapeutics, Inc.
IOVA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.91-0.51%
2026-06-18
Price Chart
Iovance Biotherapeutics, Inc.+91.67%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.75B |
| Revenue | $286M |
| Net Income | $-354M |
| Total Assets | $926M |
| Net Assets | $722M |
| Value | |
| P/B | 2.42x |
| P/S | 6.11x |
| FCF Yield | -17.47% |
| Profitability | |
| ROE | -49.03% |
| ROA | -38.23% |
| Op. Margin | -127.16% |
| Revenue Growth | 44.82% |
| Financial Health | |
| Debt Ratio | 28.25% |
| Total Debt | $47M |
| FCF | $-305M |
| Cash | $197M |
| Current Ratio | 3.60x |
| Performance | |
| 1Y Return | 91.67% |
| 1M Return | 13.01% |
| From 52W High | -30.55% |
| 1Y MDD | -54.41% |
| Trading | |
| Volume | 17,404,374 shares |
| Trading Value | $69M |
| Per Share | |
| EPS | $-0.96 |
| BPS | $1.72 |